...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>SIAM journal on applied dynamical systems >Clinical Characteristics and Treatment Outcome of Chinese Patients With Systemic Amyloid Light-Chain Amyloidosis: A Retrospective Single-Center Analysis
【24h】

Clinical Characteristics and Treatment Outcome of Chinese Patients With Systemic Amyloid Light-Chain Amyloidosis: A Retrospective Single-Center Analysis

机译：中国全身淀粉样蛋白轻链淀粉状症患者临床特征及治疗结果：回顾性单中心分析

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

A retrospective analysis of 123 amyloid light-chain amyloidosis patients in a single center of China found that compared to other studies abroad, patients were younger and more had organ involvement. Hypoalbuminemia, renal failure, and heart involvement were important to survival. Additionally, rapid treatment response time (within 3 months) significantly improved prognosis.
机译：回顾性分析123个淀粉样蛋白轻链淀粉样蛋白症患者在中国的单一中心发现，与其他海外研究相比，患者年龄较小，机箱受累。 低钠抑制症，肾功能衰竭和心脏病患者对生存是重要的。 此外，快速治疗响应时间（3个月内）显着提高预后。

著录项

  • 来源
  • 作者

    Zhao Qian; Li Feng; Song Ping; Zhou Xiaogang; Wang Liping; Yu Yaping; An Zhiming; Wang Xuli; Zhai Yongping;

  • 作者单位

    Nanjing Univ Sch Med Jinling Hosp Dept Hematol Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Sch Med Jinling Hosp Dept Hematol Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Sch Med Jinling Hosp Dept Hematol Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Sch Med Jinling Hosp Dept Hematol Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Sch Med Jinling Hosp Dept Hematol Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Sch Med Jinling Hosp Dept Hematol Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Sch Med Jinling Hosp Dept Hematol Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Sch Med Jinling Hosp Dept Hematol Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Sch Med Jinling Hosp Dept Hematol Nanjing 210008 Jiangsu Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 动力系统理论;
  • 关键词

    Bortezomib; HDM/SCT; Melphalan; Overall survival; Treatment response;

    机译：Bortezomib;HDM / SCT;Melphalan;整体存活;治疗反应;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号